The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index; 23 of the 29 sources its claims cite were checked for support.
A post-implementation evaluation of BioFire FilmArray Meningitis/Encephalitis panel for pathogen detection in cerebrospinal fluid with a special focus on clinical significance of HHV-6
Open accessAbstract
Syndromic molecular testing for the diagnosis of infections has been advantageous given high sensitivity and rapid diagnostics; however, challenges remain with appropriate interpretation. A post-implementation evaluation of the cerebrospinal fluid (CSF) BioMerieux BioFire FilmArray Meningitis/Encephalitis panel in an adult and pediatric population was performed. The aims were to assess the prevalence and epidemiology of all targets and to correlate laboratory parameters with results from human herpesvirus 6 (HHV-6) detection in CSF to identify opportunities to apply diagnostic stewardship. A retrospective observational study was conducted on CSF Nucleic Acid Amplification Test (NAAT) results performed at a referral laboratory in Australia between 19 March 2022 and 31 July 2023. Laboratory data were extracted, with additional clinical data obtained for the HHV-6 positive subcohort. Of 1,490 CSF specimens identified, 287 (19.3%) had a positive NAAT. Non-neonate CSF specimens with white cell count (WCC) above the normal range had a higher proportion of NAAT-positive rates (35.3%) compared to those with WCC < 5 × 10 6 cells/L (6.5%) ( P < 0.001). A positive NAAT result was detected in 90 (39.1%) specimens in neonates, with enterovirus and parechovirus detected most frequently. Concordance of bacterial and fungal targets and culture results was seen in 16 (33.3%) specimens. Forty-eight CSF specimens had HHV-6 detected, with a median age of 24.3 years (interquartile range: 0.5–58.7) at collection and 10 specimens with a documented immunocompromised status. This study highlights the caution required when utilizing syndromic diagnostic assays for the detection of CSF pathogens without associated diagnostic stewardship strategies and the potential utility of CSF WCC as a criterion for further review. IMPORTANCE Utilization of molecular testing methods enables rapid and high-sensitivity diagnostics, which can have significant impacts upon clinical outcomes in meningitis and encephalitis. However, challenges remain with the interpretation of results when syndromic panels are used, such as with the detection of human herpesvirus 6 (HHV-6) in cerebrospinal fluid (CSF). This study aimed to evaluate the BioMerieux BioFire FilmArray Meningitis/Encephalitis panel for the detection of pathogens in CSF in an adult and pediatric population. Data demonstrated that performing CSF nucleic acid amplification testing without diagnostic stewardship strategies in place can be associated with increased detection of potential bystander pathogens, including HHV-6.
Overview
CoChat Summary
## TL;DR
This retrospective post-implementation study of 1,490 CSF specimens found that BioFire FilmArray Meningitis/Encephalitis testing was positive in 19.3% overall, with HHV-6 detected in 48 specimens (3.2%). The authors conclude that HHV-6 in CSF is often hard to interpret and that using CSF white cell count as a stewardship trigger for non-neonate samples may reduce low-value testing.
## Key findings
- Among 1,490 CSF specimens from 1,457 patients, 287 specimens (19.3%) were NAAT-positive; 5 specimens (0.3%) had more than one organism detected.
- Enterovirus was the most common target overall, detected in 130 specimens (8.7%); HHV-6 was detected in 48 specimens (3.2%).
- For non-neonate specimens, NAAT positivity was 35.3% when CSF WCC was above the normal range versus 6.5% when WCC was within normal range (P < 0.001).
- In the HHV-6-positive subcohort, 41.7% of specimens had CSF RBC above the normal range, 25% (12/48) had elevated protein, and 14.6% (7/48) received antiviral therapy; 10 specimens had documented immunocompromised status.
## Methods
- Retrospective observational study at a single referral laboratory in Newcastle, Australia, covering 19 March 2022 to 31 July 2023.
- Included pediatric and adult CSF specimens obtained by lumbar puncture with at least 200 µL collected; excluded forensic, repeat same-admission, and out-of-region specimens.
- Extracted laboratory and clinical data from the LIS and used descriptive statistics plus chi-square tests to compare categorical variables.
## Limitations
- The paper explicitly states it was retrospective and had reduced sample size in some subcohorts; no power calculations were performed.
- Full clinical and laboratory data were not available on all patients, and there was no data on the prevalence of ciHHV-6 or radiological imaging to support HHV-6 encephalitis diagnoses.
- Evident from the text: HHV-6 serology and quantitative testing were only done in a minority of HHV-6-positive cases, which limits interpretation of whether detections represented infection, reactivation, or chromosomal integration.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
17 Valid · 3 Not valid · 4 Not checked · 44 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“the clinical symptoms remain nonspecific, including headache, delirium, and seizures (28)”
§ A post-implementation evaluation of BioFire FilmArray Meningitis/Encephalitis panel for pathogen detection in cerebrospinal fluid with a special focus on clinical significance of HHV-6 > DISCUSSION
What the sources say
- Supportedcites [28] Rebechi MT, Bork JT, Riedel DJ. 2021. HHV-6 encephalitis after chimeric antigen receptor T-cell therapy (CAR-T): 2 case reports and a brief review of the literature. Open Forum Infect Dis 8: ofab470. doi: 10.1093/ofid/ofab470 34738024 PMC8562470 source
The paper’s discussion of HHV-6 encephalitis after HSCT says presentation typically includes headache and acute confusion, and that seizures are common. In “Challenges in Diagnosis,” it describes delirium and substantial symptom overlap with CAR-T-associated neurotoxicity, supporting the characterization as nonspecific. (LLM, conf=0.90)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Thereby, the presence may represent serum levels, rather than be representative of CNS infections (25).”
§ A post-implementation evaluation of BioFire FilmArray Meningitis/Encephalitis panel for pathogen detection in cerebrospinal fluid with a special focus on clinical significance of HHV-6 > DISCUSSION
What the sources say
- Supportedcites [25] Chia XT, Wong HLM, Loh JS. 2024. Human herpesvirus-6 infection in a critically ill and immunocompetent patient: a case report. J Med Case Rep 18. doi: 10.1186/s13256-024-04387-5 PMC10905906 38424575 source
In Discussion and conclusions (page not provided), the authors say that a traumatic lumbar puncture with 1,091 RBC/µL could have contaminated the CSF with serum blood, making the positive HHV-6 PCR result potentially attributable to serum rather than encephalitis. They also note that clinical findings supported their interpretation of encephalitis; the citing claim appropriately presents contamination as a possibility. (LLM, conf=0.94)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The incidence of reported HHV-6 associated meningoencephalitis or transverse myelitis in the HHV-6 positive cohort (22.9%) was similar to that reported by Pandey et al. (24).”
§ A post-implementation evaluation of BioFire FilmArray Meningitis/Encephalitis panel for pathogen detection in cerebrospinal fluid with a special focus on clinical significance of HHV-6 > DISCUSSION
What the sources say
- Supportedcites [24] Pandey U, Greninger AL, Levin GR, Jerome KR, Anand VC, Dien Bard J. 2020. Pathogen or bystander: clinical significance of detecting human herpesvirus 6 in pediatric cerebrospinal fluid. J Clin Microbiol 58: e00313-20. doi: 10.1128/JCM.00313-20 32102858 PMC7180253 source
The Results report that 5 of 25 HHV-6-positive patients (20%) were diagnosed with HHV-6 meningitis or meningoencephalitis. The Discussion likewise describes CNS infections in 20% of the HHV-6-positive cohort, supporting the comparison with 22.9%. (LLM, conf=0.90)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“There is a consensus in the literature that a whole blood viral load >5.5log10 copies/mL or serum viral load >3.5log10 copies/mL is suggestive of chromosomal integration (14, 24, 29, 30).”
§ A post-implementation evaluation of BioFire FilmArray Meningitis/Encephalitis panel for pathogen detection in cerebrospinal fluid with a special focus on clinical significance of HHV-6 > DISCUSSION
What the sources say
- Could not verifycites [14] Kestenbaum LA, Ebberson J, Zorc JJ, Hodinka RL, Shah SS. 2010. Defining cerebrospinal fluid white blood cell count reference values in neonates and young infants. Pediatrics 125: 257– 264. doi: 10.1542/peds.2009-1181 20064869 PMC3033868 sourceExperimental — accuracy not yet measured
The Results and Discussion report cerebrospinal-fluid white blood cell reference values in infants and discuss enterovirus PCR testing. Searches for the stated whole-blood and serum viral-load thresholds and for chromosomal integration found no passage addressing them; no page numbers were available in our copy. (LLM, conf=0.78)
- Partly supportedcites [24] Pandey U, Greninger AL, Levin GR, Jerome KR, Anand VC, Dien Bard J. 2020. Pathogen or bystander: clinical significance of detecting human herpesvirus 6 in pediatric cerebrospinal fluid. J Clin Microbiol 58: e00313-20. doi: 10.1128/JCM.00313-20 32102858 PMC7180253 sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) says that HHV-6 levels above 300,000 copies/mL of whole blood are highly suggestive of chromosomal integration, approximately matching the claimed >5.5 log10 threshold. The paper does not give the claimed serum threshold of >3.5 log10 copies/mL, so it supports only the whole-blood part. (LLM, conf=0.88)
- Partly supportedcites [29] Pellett PE, Ablashi DV, Ambros PF, Agut H, Caserta MT, Descamps V, Flamand L, Gautheret-Dejean A, Hall CB, Kamble RT, et al.. 2012. Chromosomally integrated human herpesvirus 6: questions and answers. Rev Med Virol 22: 144– 155. doi: 10.1002/rmv.715 22052666 PMC3498727 sourceExperimental — accuracy not yet measured
Table 2 and the ciHHV-6 Q&A (p. 149) support the >5.5 log10 copies/mL whole-blood threshold as suggestive of chromosomal integration. They do not give a >3.5 log10 copies/mL serum threshold; the Q&A instead says serum testing is unreliable for identifying ciHHV-6. (LLM, conf=0.90)
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“our study cohort included a majority (79.2%) without an immunocompromised status documented (25).”
§ A post-implementation evaluation of BioFire FilmArray Meningitis/Encephalitis panel for pathogen detection in cerebrospinal fluid with a special focus on clinical significance of HHV-6 > DISCUSSION
What the sources say
- Could not verifycites [25] Chia XT, Wong HLM, Loh JS. 2024. Human herpesvirus-6 infection in a critically ill and immunocompetent patient: a case report. J Med Case Rep 18. doi: 10.1186/s13256-024-04387-5 PMC10905906 38424575 sourceExperimental — accuracy not yet measured
The Case presentation describes immunodeficiency screening in one patient, not a study cohort. Searches for 79.2% and for a cohort's immunocompromised status found no such result in our copy, so the cited case report cannot verify the citing authors' cohort figure. (LLM, conf=0.77)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
28 more claims · 2 with their cited sources checked
Create a free account to see all 68 claims and every source verdict.
- It may state two separate claims as one. 21
- Probably not a substantial claim. 23
- The quote only partly states this claim. 1
Citations
Cites
Leber, A. L., Everhart, K., Balada-Llasat, J.-M., Cullison, J., Daly, J., Holt, S., Lephart, P., Salimnia, H., Schreckenberger, P. C., DesJarlais, S., et al. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.00730-16 · Cited by 609 · cited 5×
“Of the two positive NAAT bacterial detection, S. pneumoniae was deemed clinically unlikely and a possible false positive due to contamination, which has previously been reported by Leber et al. (16).”
InfluentialZunt, J. R., Kassebaum, N. J., Blake, N., Glennie, L., Wright, C., Nichols, E., Abd-Allah, F., Abdela, J., Abdelalim, A., Adamu, A. A., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30387-9 · Cited by 385
Chromosomally integrated human herpesvirus 6: questions and answers
Pellett, P. E., Ablashi, D. V., Ambros, P. F., Agut, H., Caserta, M. T., Descamps, V., Flamand, L., Gautheret‐Dejean, A., Hall, C. B., Kamble, R. T., et al. (2012) · Reviews in Medical Virology · doi:10.1002/rmv.715 · Cited by 377
Tansarli, G. S., & Chapin, K. C. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.11.016 · Cited by 263
Nam Leong, H., Tuke, P. W., Tedder, R. S., Khanom, A. B., Eglin, R. P., Atkinson, C. E., Ward, K. N., Griffiths, P. D., & Clark, D. A. (2007) · Journal of Medical Virology · doi:10.1002/jmv.20760 · Cited by 212
Ward, K. N., Leong, H. N., Thiruchelvam, A. D., Atkinson, C. E., & Clark, D. A. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02115-06 · Cited by 174
Defining Cerebrospinal Fluid White Blood Cell Count Reference Values in Neonates and Young Infants
Kestenbaum, L. A., Ebberson, J., Zorc, J. J., Hodinka, R. L., & Shah, S. S. (2010) · Pediatrics · doi:10.1542/peds.2009-1181 · Cited by 168
Diagnostic Stewardship: Opportunity for a Laboratory–Infectious Diseases Partnership
Patel, R., & Fang, F. C. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy077 · Cited by 127
Green, D. A., Pereira, M., Miko, B., Radmard, S., Whittier, S., & Thakur, K. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy288 · Cited by 110
Global magnitude of encephalitis burden and its evolving pattern over the past 30 years
Wang, H., Zhao, S., Wang, S., Zheng, Y., Wang, S., Chen, H., Pang, J., Ma, J., Yang, X., & Chen, Y. (2022) · Journal of Infection · doi:10.1016/j.jinf.2022.04.026 · Cited by 101
Cited by
Recent advances and trends in critical care of neuro-infectious disease
Crayle, J. I., & Arshi, B. (2026) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000001413
Denominator and Workflow Dependence of Age-Specific Viral Detection in Cerebrospinal Fluid
Kim, J. Y., Kwon, H.-J., Jeon, J., & Kim, J. K. (2026) · Pathogens · doi:10.3390/pathogens15090905 · Cited by 1
Metadata
- Authors
- Perera, M., Varadhan, H., & Oon, A.
- Affiliations
- John Hunter Hospital (AU)
- Corresponding author
- Perera, Manoshi
- Venue
- Microbiology spectrum
- Publisher
- American Society for Microbiology
- Published
- 2026-01-06
- Volume
- 14
- Issue
- 1
- Pages
- e0062025-e0062025
- ISSN
- 2165-0497 (ISSN-L)
- PMC
- PMC12772252
- OpenAlex
- W4416790464
- Cited by
- 4
- References
- 29
- Citations by year
- 2026: 4
- FWCI
- 3.05
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (vor)
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Microbiology Spectrum (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Infectious Encephalopathies and Encephalitis
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Keywords
- cerebrospinal fluid, meningitis, encephalitis, human herpesvirus 6, nucleic acid amplification tests, diagnostic stewardship, enterovirus, parechovirus, immunocompromised patients
- MeSH terms
- Clinical Relevance, Adolescent, Adult, Australia, Cerebrospinal Fluid, Child, Child, Preschool, Female, Humans, Infant, Infant, Newborn, Male, Meningitis, Middle Aged, Retrospective Studies, Sensitivity and Specificity, Herpesvirus 6, Human, Encephalitis, Viral, Roseolovirus Infections, Nucleic Acid Amplification Techniques, Molecular Diagnostic Techniques, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-29, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-29 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A post-implementation evaluation of BioFire FilmArray Meningitis/Encephalitis panel for pathogen detection in cerebrospinal fluid with a special focus on clinical significance of HHV-6. https://app.cochat.ai/papers/10.1128/spectrum.00620-25
- The paper
- Perera, M., Varadhan, H., & Oon, A. (2026). A post-implementation evaluation of BioFire FilmArray Meningitis/Encephalitis panel for pathogen detection in cerebrospinal fluid with a special focus on clinical significance of HHV-6. Microbiology spectrum. https://doi.org/10.1128/spectrum.00620-25
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.